Matrix Laboratories Limited

New Document

Financial Year 2009 - 2010

Quarter I
(June 2009)

Financial Year 2008 - 2009

Quarter IV
(March 2009)

Quarter III
(December 2008)

Quarter II
(September 2008)

Quarter I
(June 2008)

Financial Year 2007 - 2008

Quarter IV
(March 2008)

Quarter III
(December 2007)

Quarter II
(September 2007)

Quarter I
(June 2007)

Financial Year 2006 - 2007

Quarter IV
(March 2007)

Quarter III
(December 2006)

Quarter II
(September 2006)

Quarter I
(June 2006)

Financial Year 2005 - 2006

Quarter IV
(March 2006)

Quarter III
(December 2005)

Quarter II
(September 2005)

Quarter I
(June 2005)

Financial Year 2004 - 2005

Quarter IV
(March 2005)

Quarter III
(December 2004)

Quarter II
(September 2004)

Quarter I
(June 2004)

Financial Year 2003 - 2004

Quarter IV
(March 2004)

Quarter III
(December 2003)

Quarter II
(September 2003)

Quarter I
(June 2003)

Financial Year 2002 - 2003

Quarter IV
(March 2003)

Quarter III
(December 2002)

Quarter II
(September 2002)

Quarter I
(June 2002)

AUDITED FINANCIAL RESULTS
FOR
THE QUARTER ENDED 30TH SEPTEMBER 2003

(Rs.in Million )

Sl. No	Particulars	Quarter ended 30th September		Half Year ended 30th September		Year Ended 31st March 2003 (Audited)	Year Ended 31st March 2002 (Audited)
		2003 (Audited)	2002 ( Audited)	2003 (Audited)	2002 ( Audited)
	Gross Sales \| \| \| - Exports \| \| \| - Domestic	1421.17 735.04 686.13	603.19 416.81 186.38	2691.44 1503.10 1188.34	1110.07 816.54 293.53	4169.27 2888.47 1280.80	1038.90 208.36 830.54
1	Net Sales	1364.27	577.77	2575.32	1067.31	3990.30	932.07
2	Other Income	21.65	-	30.98	0.76	7.72	1.79
3	Total Expenditure a) (Increase) / Decrease in Stock b) Consumption of Raw materials c) Staff Cost d) Other Expenditure	938.32 (189.81) 789.60 52.74 285.79	308.39 (19.69) 211.76 14.65 101.67	1759.62 (219.86) 1368.91 97.71 512.86	575.57 5.22 355.79 27.83 186.73	2710.89 21.61 1672.08 142.24 874.96	826.36 (74.38) 670.53 49.46 180.75
4	Interest	24.13	11.52	44.62	20.08	260.39	16.73
5	Depreciation	27.72	7.34	49.22	12.31	71.96	15.26
6	Profit before Tax (1+2-3-4-5)	395.75	250.52	752.84	460.11	954.78	75.51
7 8	Provision for Tax - Current \| \| \| \| \| \| \| \| \| \| \| \| \| \| \| \| \| \| \| \| \| - Deferred	50.00 25.00	9.50 -	75.00 50.00	12.50 3.63	57.00 147.24	4.60 26.08
9	Profit after Tax (6-7-8)	320.75	241.02	627.84	443.98	750.54	44.83
10	Equity Capital (fully paid up Rs. 10 each)	123.03	71.94	123.03	71.94	97.18	71.88
11	Share Capital suspense					25.79
12	Reserves excluding revaluation reserves					892.62	143.25
13	Basic E.P.S - Not Annualised (Rs.) \| \| \| \| \| \| \| \| \| \| \| \| \| \| \| \| - Annualised (Rs.) Diluted E.P.S - Not Annualised(Rs.) \| \| \| \| \| \| \| \| \| \| \| \| \| \| \| \| \| \| \| \| - Annualised (Rs.)	26.07 104.28 26.07 104.28	33.50 134.00 33.50 134.00	51.03 102.06 51.03 102.06	61.72 123.44 61.72 123.44	98.78 73.74	10.83 10.83
14	Aggregate of Non promoters Shareholding Number of shares Percentage of Shareholding	6375134 51.84%	4430164 61.64%	6375134 51.84%	4430164 61.64%	4430164 45.59%	5515484 76.74%

Notes :

1. The Audited results for the year ended 31st March 2003 reflect the results
| | | of the amalgamated company.The figures for the corresponding quarter /
| | | half year in the previous year pertain only to that of Matrix Laboratories
| | | Limited and to that extent not comparable.

2. The above audited results were reviewed by the Audit Committee,
| | | considered and approved by the Board of Directors at their meeting held
| | | on 8th November 2003.

3. The activities of the Company relate to only one segment i.e. Pharmaceuticals.

4. Summary of Investor Complaints

Pending as on 1.7.2003 Received during the
Quarter Resolved Pending as on
30.9.2003

Nil 4 4 Nil

	For and on behalf of the Board
Place : Secunderabad Date : 8th November 2003	Sd/- N.PRASAD Chairman & CEO